Viropro Inc., a public company incorporated under the laws of the state of Nevada, specializes in cell line and biopharmaceutical process development.  

The manufacturing processes developed are out-licensed to various international partners who produce and distribute the final product.  The company is currently seeking partnerships for its biosimilar (aka follow-on biologics) cell lines and manufacturing processes. 

Viropro uses patented cell lines and expression vectors that clearly out-perform the industry standards and allow partnering companies to obtain industrially competitive yields.  Our technology is ideally suited for Monoclonal Antibody process development.

See our List of Services Offered here

Contact info:

Mr. Serge Beausoleil 514 739 8776:  For IR and Market-related enquiries.
Mr. Claude Gingras 949 783 6573:  For enquiries related to direct investment opportunities or Compliance
Dr Rajiv Datar 949 351 0860: For all other enquiries related to Corporate, Business and Scientific matters


 

                                                                                                                                                                                                       

 


 

2010-08-11
Viropro reorganizes -

2010-07-08
Viropro to seek supplemental listing -

2010-06-01
Biologics to post record results -

2010-04-28
Viropro initiates discussions with Intas Biopharmaceuticals Ltd -